Law360, New York (March 19, 2008, 12:00 AM EDT) -- A federal appeals court has affirmed a ruling allowing Roche Holding AG to import its anemia drug Mircera into the U.S. as long as the company doesn't sell it. But the court disagrees with the International Trade Commission's position that the ITC doesn't have jurisdiction over the case.
The U.S. Court of Appeals for the Federal Circuit issued an order Wednesday sending the case back to the ITC, finding that the commission does have the authority to determine whether Roche's activities in developing and importing the...
ITC Must Consider Amgen, Roche Dispute Over Mircera
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
